Skip navigation

Chemical Lipids

251–300 of 10,230 results.
  Chemical Phenotype Co-Mentioned Terms Interaction Organisms Anatomy Inference Network References
251. 1-nonanol sensory perception of chemical stimulus positive regulation of neuronal action potential [1-nonanol results in increased sensory perception of chemical stimulus] which results in increased positive regulation of neuronal action potential 1: Uraba lugens Sensilla | Olfactory Receptor Neurons   1
252. 1-nonanol sensory perception of chemical stimulus 1-nonanol results in increased sensory perception of chemical stimulus 1: Uraba lugens Sensilla | Olfactory Receptor Neurons   1
253. 1-nonanol behavior Dopamine [Dopamine affects behavior] which affects the susceptibility to 1-nonanol 1: Caenorhabditis elegans     1
254. 1-octen-3-ol chemosensory behavior 1-octen-3-ol results in increased chemosensory behavior 1: Stomoxys calcitrans     1
255. 1-octen-3-ol response to odorant Oils, Volatile 1-octen-3-ol promotes the reaction [Oils, Volatile results in increased response to odorant] 1: Stomoxys calcitrans Arthropod Antennae   1
256. 1-octen-3-ol flight behavior 1-octen-3-ol results in increased flight behavior 1: Stomoxys calcitrans     1
257. 1-octen-3-ol positive regulation of host-seeking behavior 1-octen-3-ol results in increased positive regulation of host-seeking behavior 1: Stomoxys calcitrans     1
258. 1-octen-3-ol response to odorant 1-octen-3-ol results in increased response to odorant 1: Stomoxys calcitrans Arthropod Antennae   1
259. 1-octen-3-ol response to odorant Oils, Volatile Oils, Volatile promotes the reaction [1-octen-3-ol results in increased response to odorant] 1: Stomoxys calcitrans Arthropod Antennae   1
260. 1-octen-3-ol flight behavior Oils, Volatile Oils, Volatile inhibits the reaction [1-octen-3-ol results in increased flight behavior] 1: Stomoxys calcitrans     1
261. 1-octen-3-ol recognition of host 1-octen-3-ol results in increased recognition of host 1: Stomoxys calcitrans     1
262. 1-octen-3-ol positive regulation of host-seeking behavior Oils, Volatile Oils, Volatile inhibits the reaction [1-octen-3-ol results in increased positive regulation of host-seeking behavior] 1: Stomoxys calcitrans     1
263. 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine cell proliferation AG 1879 AG 1879 inhibits the reaction [1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased cell proliferation] 1: Rattus norvegicus Muscle, Smooth, Vascular | Cells, Cultured
3 genes: IL1A | SRC | TNF
1
264. 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine cell proliferation resveratrol resveratrol inhibits the reaction [1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased cell proliferation] 1: Rattus norvegicus Muscle, Smooth, Vascular | Cells, Cultured
3 genes: IL1A | SRC | TNF
1
265. 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine cell proliferation 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased cell proliferation] 1: Rattus norvegicus Muscle, Smooth, Vascular | Cells, Cultured
3 genes: IL1A | SRC | TNF
1
266. 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine cell proliferation 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased cell proliferation 1: Rattus norvegicus Muscle, Smooth, Vascular | Cells, Cultured
3 genes: IL1A | SRC | TNF
1
267. 1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine lipid oxidation Copper Sulfate | Hydrogen Peroxide [[Copper Sulfate co-treated with Hydrogen Peroxide] results in increased lipid oxidation] which results in increased oxidation of 1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine     1
268. 1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine lipid oxidation Copper Sulfate | Hydrogen Peroxide | Pimelic Acids [[[Copper Sulfate co-treated with Hydrogen Peroxide] results in increased lipid oxidation] which results in increased oxidation of 1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine] which results in increased abundance of Pimelic Acids analog     1
269. 1-palmitoyl-2-oleoyl-glycero-3-phosphatidic acid calcium ion import linsidomine linsidomine promotes the reaction [1-palmitoyl-2-oleoyl-glycero-3-phosphatidic acid results in increased calcium ion import] 1: Rattus norvegicus Myocytes, Cardiac | Cells, Cultured   1
270. 1-palmitoyl-2-oleoyl-glycero-3-phosphatidic acid calcium ion import 1-palmitoyl-2-oleoyl-glycero-3-phosphatidic acid results in increased calcium ion import 1: Rattus norvegicus Myocytes, Cardiac | Cells, Cultured   1
271. 20-carboxyleukotriene B4 regulation of fatty acid metabolic process Tetrachlorodibenzodioxin [Tetrachlorodibenzodioxin results in increased regulation of fatty acid metabolic process] which results in increased abundance of 20-carboxyleukotriene B4 1: Rattus norvegicus Serum   1
272. 20-hydroxy-5,8,11,14-eicosatetraenoic acid lactate dehydrogenase activity Cisplatin 20-hydroxy-5,8,11,14-eicosatetraenoic acid promotes the reaction [Cisplatin results in increased lactate dehydrogenase activity] 1: Homo sapiens Kidney Tubules, Proximal | Epithelial Cells | Cell Line   1
273. 20-hydroxy-5,8,11,14-eicosatetraenoic acid regulation of blood pressure Sodium Chloride, Dietary 20-hydroxy-5,8,11,14-eicosatetraenoic acid affects the reaction [Sodium Chloride, Dietary affects regulation of blood pressure] 1: Rattus norvegicus Arteries 1 gene: POMC 1
274. 20-hydroxy-5,8,11,14-eicosatetraenoic acid vasoconstriction SQ 29548 SQ 29548 inhibits the reaction [20-hydroxy-5,8,11,14-eicosatetraenoic acid results in increased vasoconstriction] 1: Mus musculus Aorta   1
275. 20-hydroxy-5,8,11,14-eicosatetraenoic acid renal sodium excretion CLOCK [CLOCK protein affects the abundance of 20-hydroxy-5,8,11,14-eicosatetraenoic acid] which affects renal sodium excretion 1: Mus musculus Urine   1
276. 20-hydroxy-5,8,11,14-eicosatetraenoic acid epoxygenase P450 pathway Nifedipine [Nifedipine results in increased epoxygenase P450 pathway] which results in increased chemical synthesis of 20-hydroxy-5,8,11,14-eicosatetraenoic acid 1: Rattus norvegicus Kidney
2 genes: CYP2C8 | CYP4A11
1
277. 20-hydroxy-5,8,11,14-eicosatetraenoic acid epoxygenase P450 pathway Cyclosporine | Verapamil Verapamil inhibits the reaction [[Cyclosporine results in increased epoxygenase P450 pathway] which results in increased chemical synthesis of 20-hydroxy-5,8,11,14-eicosatetraenoic acid] 1: Rattus norvegicus Kidney
2 genes: CYP2C8 | CYP4A11
1
278. 20-hydroxy-5,8,11,14-eicosatetraenoic acid regulation of blood pressure Clofibrate | Desoxycorticosterone | Sodium Chloride, Dietary [Clofibrate inhibits the reaction [[Sodium Chloride, Dietary co-treated with Desoxycorticosterone] results in increased regulation of blood pressure]] which results in increased abundance of 20-hydroxy-5,8,11,14-eicosatetraenoic acid 1: Mus musculus Cardiovascular System 1 gene: POMC 1
279. 20-hydroxy-5,8,11,14-eicosatetraenoic acid epoxygenase P450 pathway Verapamil [Verapamil results in increased epoxygenase P450 pathway] which results in increased chemical synthesis of 20-hydroxy-5,8,11,14-eicosatetraenoic acid 1: Rattus norvegicus Kidney
2 genes: CYP2C8 | CYP4A11
1
280. 20-hydroxy-5,8,11,14-eicosatetraenoic acid inorganic cation transmembrane transport 20-hydroxy-5,8,11,14-eicosatetraenoic acid results in decreased inorganic cation transmembrane transport 1: Mus musculus Kidney | Epithelial Cells | Cell Line   1
281. 20-hydroxy-5,8,11,14-eicosatetraenoic acid epoxygenase P450 pathway N-hydroxy-N'-(4-butyl-2-methylphenyl)formamidine [N-hydroxy-N'-(4-butyl-2-methylphenyl)formamidine results in decreased epoxygenase P450 pathway] which results in decreased chemical synthesis of 20-hydroxy-5,8,11,14-eicosatetraenoic acid 1: Rattus norvegicus Kidney | Blood Vessels
2 genes: CYP2C8 | CYP4A11
1
282. 20-hydroxy-5,8,11,14-eicosatetraenoic acid epoxygenase P450 pathway Cyclosporine | Nifedipine Nifedipine inhibits the reaction [[Cyclosporine results in increased epoxygenase P450 pathway] which results in increased chemical synthesis of 20-hydroxy-5,8,11,14-eicosatetraenoic acid] 1: Rattus norvegicus Kidney
2 genes: CYP2C8 | CYP4A11
1
283. 20-hydroxy-5,8,11,14-eicosatetraenoic acid vasodilation Indomethacin Indomethacin inhibits the reaction [20-hydroxy-5,8,11,14-eicosatetraenoic acid results in increased vasodilation] 1: Mus musculus Basilar Artery   1
284. 20-hydroxy-5,8,11,14-eicosatetraenoic acid vasodilation 20-hydroxy-5,8,11,14-eicosatetraenoic acid results in increased vasodilation 1: Mus musculus Basilar Artery   1
285. 20-hydroxy-5,8,11,14-eicosatetraenoic acid arachidonic acid metabolic process sodium arsenite [sodium arsenite affects arachidonic acid metabolic process] which results in decreased abundance of 20-hydroxy-5,8,11,14-eicosatetraenoic acid 1: Mus musculus Brain
3 genes: CYP4A1 | CYP4A11 | CYP4A2
1
286. 20-hydroxy-5,8,11,14-eicosatetraenoic acid inorganic cation transmembrane transport Rubidium [20-hydroxy-5,8,11,14-eicosatetraenoic acid results in decreased inorganic cation transmembrane transport] which results in decreased uptake of Rubidium 1: Mus musculus Kidney | Epithelial Cells | Cell Line   1
287. 20-hydroxy-5,8,11,14-eicosatetraenoic acid cell death 20-hydroxy-5,8,11,14-eicosatetraenoic acid results in increased cell death 1: Homo sapiens Kidney Tubules, Proximal | Epithelial Cells | Cell Line   1
288. 20-hydroxy-5,8,11,14-eicosatetraenoic acid vasoconstriction 20-hydroxy-5,8,11,14-eicosatetraenoic acid results in increased vasoconstriction 1: Mus musculus Aorta   1
289. 20-hydroxy-5,8,11,14-eicosatetraenoic acid epoxygenase P450 pathway Cyclosporine [Cyclosporine results in increased epoxygenase P450 pathway] which results in increased chemical synthesis of 20-hydroxy-5,8,11,14-eicosatetraenoic acid 1: Rattus norvegicus Kidney
2 genes: CYP2C8 | CYP4A11
1
290. 20-hydroxy-5,8,11,14-eicosatetraenoic acid lactate dehydrogenase activity 20-hydroxy-5,8,11,14-eicosatetraenoic acid results in increased lactate dehydrogenase activity 1: Homo sapiens Kidney Tubules, Proximal | Epithelial Cells | Cell Line   1
291. 20-hydroxy-5,8,11,14-eicosatetraenoic acid calcium-activated potassium channel activity 20-hydroxy-5,8,11,14-eicosatetraenoic acid affects calcium-activated potassium channel activity 1: Rattus norvegicus Brain | Astrocytes | Cells, Cultured   1
292. 20-hydroxyeicosa-5(Z),14(Z)-dienoic acid positive regulation of vasoconstriction 20-hydroxyeicosa-5(Z),14(Z)-dienoic acid results in increased positive regulation of vasoconstriction 1: Rattus norvegicus Kidney Glomerulus | Arterioles 1 gene: AKT1 1
293. 20-hydroxyeicosa-5(Z),14(Z)-dienoic acid anoikis isoliquiritigenin 20-hydroxyeicosa-5(Z),14(Z)-dienoic acid inhibits the reaction [isoliquiritigenin results in increased anoikis] 1: Homo sapiens Breast | Cell Line, Tumor 1 gene: AKT1 1
294. 20-hydroxyeicosa-6(Z),15(Z)-dienoic acid positive regulation of vasoconstriction 2-chloro-N(6)cyclopentyladenosine 20-hydroxyeicosa-6(Z),15(Z)-dienoic acid inhibits the reaction [2-chloro-N(6)cyclopentyladenosine results in increased positive regulation of vasoconstriction] 1: Rattus norvegicus Kidney Glomerulus | Arterioles   1
295. 20-hydroxyeicosa-6(Z),15(Z)-dienoic acid positive regulation of vasoconstriction 20-hydroxyeicosa-6(Z),15(Z)-dienoic acid results in decreased positive regulation of vasoconstriction 1: Rattus norvegicus Kidney Glomerulus | Arterioles   1
296. 20-hydroxyprostaglandin E2 vasodilation 20-hydroxyprostaglandin E2 results in increased vasodilation 1: Mus musculus Basilar Artery   1
297. 20-hydroxyvitamin D2 drug metabolic process 22-hydroxycholesterol [22-hydroxycholesterol results in decreased drug metabolic process] which results in decreased hydroxylation of 20-hydroxyvitamin D2 1: Homo sapiens Placenta | Mitochondria   1
298. 20-hydroxyvitamin D2 drug metabolic process 22-hydroxycholesterol [22-hydroxycholesterol results in decreased drug metabolic process] which results in decreased hydroxylation of 20-hydroxyvitamin D2 1: Bos taurus Adrenal Cortex | Mitochondria   1
299. 22-hydroxycholesterol progesterone biosynthetic process 22-hydroxycholesterol results in increased progesterone biosynthetic process 1: Mus musculus Leydig Cells | Cell Line, Tumor   1
300. 22-hydroxycholesterol drug metabolic process 22-hydroxycholesterol results in decreased drug metabolic process 1: Bos taurus Adrenal Cortex | Mitochondria   1
251–300 of 10,230 results.